News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Ajay Major: PFS benefit in AMPLIFY Phase III trial in CML
Photo from Ajay Major/LinkedIn
Jul 31, 2024, 11:52

Ajay Major: PFS benefit in AMPLIFY Phase III trial in CML

Ajay Major, Lymphoma Faculty at the CU School of Medicine, shared on X:

“Press release now out: PFS benefit in AMPLIFY Phase III trial of fixed-duration acala + venetoclax +/- obinutuzumab vs investigator choice of CIT. Would be great to have a 2nd-gen BTKi plus ven time-limited combo approved.”

Read further.
Source: Ajay Major/X

Ajay Major cancer CML CU School of Medicine Leukemia Obinutuzumab OncoDaily Oncology
Blog
Jul 31, 2024, 15:50
Juan Cubillos-Ruiz: Iron chelation therapy unleashes innate immune responses that control Ovarian Cancer
Blog
Jul 31, 2024, 15:37
Mourning the loss of Michael Frumovitz
Insight
Jul 31, 2024, 15:28
Cristian Massacesi: Sharing Episode 3 of ‘Let’s Talk Cancer’ with Leora Horn
Blog
Jul 31, 2024, 15:17
Fumiko Ladd Chino: A celebration of life for Dr. Shekinah Elmore
Insight
Jul 31, 2024, 15:02
Medical Student Panel at WOA 2024
Insight
Jul 31, 2024, 14:50
Valentina Greco has named Howard Hughes Medical Institute Investigator - Yale Cancer Center
Blog
Jul 31, 2024, 14:43
Susanna F. Greer: A 'Gold Medal' in Cancer Discovery
Blog
Jul 31, 2024, 14:18
Formycon announced start of clinical phase III trial for Keytruda biosimilar candidate FYB206
Insight
Jul 31, 2024, 13:02
Tunji Alausa: John Oladapo Obafunwa appointed as the new Director General of the National Institute of Medical Research
Blog
Jul 31, 2024, 12:48
Megan-Claire Chase: Cancer experience from a teenager's perspective
Blog
Jul 31, 2024, 12:31
A Registered Nurse's advice to always be open to learning something new every chance you can - St. Elizabeth Healthcare
Insight
Jul 31, 2024, 12:26
Myeloma Paper of the Day, July 31st, suggested by Robert Orlowski